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Summary
Background The UN will formulate ambitious Sustainable Development Goals for 2030, including one for health. 
Feasible goals with some quantiﬁ able, measurable targets can inﬂ uence governments. We propose, as a quantitative 
health target, “Avoid in each country 40% of premature deaths (under-70 deaths that would be seen in the 2030 
population at 2010 death rates), and improve health care at all ages”. Targeting overall mortality and improved health 
care ignores no modiﬁ able cause of death, nor any cause of disability that is treatable (or also causes many deaths). 
40% fewer premature deaths would be important in all countries, but implies very diﬀ erent priorities in diﬀ erent 
populations. Reinforcing this target for overall mortality in each country are four global subtargets for 2030: avoid 
two-thirds of child and maternal deaths; two-thirds of tuberculosis, HIV, and malaria deaths; a third of premature 
deaths from non-communicable diseases (NCDs); and a third of those from other causes (other communicable 
diseases, undernutrition, and injuries). These challenging subtargets would halve under-50 deaths, avoid a third of the 
(mainly NCD) deaths at ages 50–69 years, and so avoid 40% of under-70 deaths. To help assess feasibility, we review 
mortality rates and trends in the 25 most populous countries, in four country income groupings, and worldwide.
Methods UN sources yielded overall 1970–2010 mortality trends. WHO sources yielded cause-speciﬁ c 2000–10 trends, 
standardised to country-speciﬁ c 2030 populations; decreases per decade of 42% or 18% would yield 20-year reductions 
of two-thirds or a third.
Results Throughout the world, except in countries where the eﬀ ects of HIV or political disturbances predominated, 
mortality decreased substantially from 1970–2010, particularly in childhood. From 2000–10, under-70 age-standardised 
mortality rates decreased 19% (with the low-income and lower-middle-income countries having the greatest absolute 
gains). The proportional decreases per decade (2000–10) were: 34% at ages 0–4 years; 17% at ages 5–49 years; 15% at 
ages 50–69 years; 30% for communicable, perinatal, maternal, or nutritional causes; 14% for NCDs; and 13% for 
injuries (accident, suicide, or homicide).
Interpretation Moderate acceleration of the 2000–10 proportional decreases in mortality could be feasible, achieving 
the targeted 2030 disease-speciﬁ c reductions of two-thirds or a third. If achieved, these reductions avoid about 
10 million of the 20 million deaths at ages 0–49 years that would be seen in 2030 at 2010 death rates, and about 
17 million of the 41 million such deaths at ages 0–69 years. Such changes could be achievable by 2030, or soon 
afterwards, at least in areas free of war, other major eﬀ ects of political disruption, or a major new epidemic.
Funding UK Medical Research Council, Norwegian Agency for Development Cooperation, Centre for Global Health 
Research, and Bill & Melinda Gates Foundation.
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Introduction
The Millennium Development Goals (MDGs) for 2015, 
adopted actively by governments in 2000, have mobilised 
action on development issues.1–3 During 2015, the UN 
will formulate 2016–30 Sustainable Development Goals, 
of which one (SDG3) will relate to health.1 Some MDGs 
deﬁ ned quantiﬁ able targets that allowed progress to be 
assessed within regions and countries, such as MDG4 
(reduce under-5 mortality from 1990 to 2015 by 
two-thirds) and MDG5 (reduce maternal mortality from 
1990 to 2015 by three-quarters). Neither goal will be 
realised by 2015, although child and maternal mortality 
will have approximately halved, but both have helped 
accelerate progress.4–8 The MDGs successfully engaged 
national leaders, with progress toward the goals reviewed 
at annual summits. High-level policy makers have 
limited time, and their engagement was facilitated by 
some targets being quantiﬁ able and (eventually) 
attainable.
The current draft of the 2016–30 SDGs includes 
17 overarching goals;1 16 are not health goals, although 
they may aﬀ ect health indirectly. The draft health goal, 
SDG3, is to “ensure healthy lives and promote well-being 
for all at all ages” (panel 1). Its 13 subtargets include 
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two numerical ones that might be achievable (if current 
progress improves): about two-thirds less maternal 
mortality and a third less non-communicable disease 
(NCD) mortality. They also include, however, ending 
preventable newborn and under-5 deaths; ending 
HIV/AIDS, tuberculosis, malaria, and neglected tropical 
diseases; substantially reducing death and illness from 
pollution; halving traﬃ  c deaths (which are currently 
increasing); universal access to sexual and reproductive 
services; and universal health coverage, with ﬁ nancial 
risk protection.
Although a few such aspirations would by 2015 
have been replaced in the ﬁ nal SDG3 by feasible 
2030 targets, there are drawbacks to retaining any 
implausible ones.15 An alternative is to accompany 
SDG3 by an overarching numerical target that could 
with serious extra eﬀ ort be feasible (by 2030 or the 
2030s), stimulating sustainable progress and 
potentially attracting endorsement from all 
governments, despite their diﬀ ering economic and 
health circumstances.
Global life expectancy is now (2010) about 70 years. 
We have deﬁ ned premature death somewhat arbitrarily 
as death before age 70 years, but considered mortality in 
the three age ranges 0–4, 5–49, and 50–69 years largely 
separately, since the predominant causes diﬀ er between 
them. We have also considered diﬀ erent countries 
separately, since the predominant causes (and available 
resources) vary greatly between countries. But, all 
countries share an appreciable risk of death before age 
70 years, reduction of which could be an appropriate 
quantitative target. Subtargets could concern particular 
causes of death, but an overarching universal target for 
all countries should include potentially feasible 
reductions in premature death as a whole. 
Based on recent trends, this target could be: “Avoid 
40% of all premature deaths in each country (ie, of the 
deaths before 70 years that would be seen in its 2030 
population if its 2010 death rates persisted—which they 
will not, since mortality is already generally decreasing), 
and improve health care at all ages”. This paper is 
mainly about the ﬁ rst part of this target (avoid 40% of 
Panel 1: Post-2015 global health goals1,9–14
A UN intergovernmental Open Working Group (OWG), 
established following the 2012 UN Sustainable Development 
Conference, is drafting 2016–30 SDGs. One overarching goal 
will be health-related, SDG3, and various UN initiatives have 
discussed what it and its subtargets could be:
High-Level Panel of Eminent Persons
This panel, chaired by the Indonesian, Liberian, and UK 
premiers, recommended for SDG3 “To ensure healthy lives”, 
with ﬁ ve targets: under-5 mortality ≤2% in all income quintiles, 
plus non-numerical targets on vaccination coverage; maternal 
deaths; sexual and reproductive health and rights; and 
HIV/AIDS, tuberculosis, malaria, NTDs and priority NCDs. 
The Sustainable Development Solutions Network
Initiated by economist Jeﬀ rey Sachs, it recommended “Health 
and wellbeing at all ages”, with three numerical targets: under-5 
mortality ≤2%; maternal mortality ≤40 deaths per 100 000 
livebirths; and under-70 NCD mortality reduced by ≥30%.
The UN Global Compact
This group, involving businesses in global development, 
proposed two targets for 2010–30: maternal mortality reduced 
by 75%; and under-5 mortality reduced by 67%.
Global Thematic Consultation on Post-2015 Health Agenda
After wide consultation (100 submitted papers and 
14 international hearings with 1600 participants), it 
recommended: build on and accelerate the MDG agenda, reduce 
the NCD burden, and ensure universal health coverage and access. 
UNICEF’s Promise Renewed
UNICEF proposed each country commit to scale up high-impact 
strategies to make 2035 under-5 mortality ≤2%.
The WHO World Health Assembly NCD Resolution
This resolution targeted reducing premature death from NCDs 
(ie, the uniformly age-standardised mortality rates at ages 
30–69 years) by 25% from 2010 to 2025.
The Lancet Commission on Investing in Health (not UN)
Chaired by economists Lawrence Summers and Dean Jamison, 
it proposed that health-system strengthening plus scale-up of 
proven, aﬀ ordable health interventions and suitable research 
and development could achieve a “grand convergence in global 
health by 2035”—reducing infectious, maternal, and child 
deaths in low or lower-middle income countries to current best 
levels in middle-income countries. 2030 targets for such 
countries are: under-5 mortality ≤2% (neonatal mortality 
≤1·1%); maternal deaths ≤94 per 100 000 livebirths; and annual 
mortality per 100 000 ≤4 for tuberculosis and ≤3 for AIDS.
The July 2014 OWG proposal for SDG3
The proposal to “ensure healthy lives and promote wellbeing 
for all at all ages” had 13 subtargets: maternal mortality 
≤70 deaths per 100 000 livebirths; end preventable newborn 
and under-5 deaths; end the epidemics of HIV/AIDS, 
tuberculosis, malaria, NTDs, and other infections; reduce 
premature NCD mortality by a third; halve traﬃ  c accident 
morbidity and mortality; strengthen treatment and prevention 
of substance abuse; universal access to sexual and reproductive 
health services; substantially reduce morbidity and mortality 
from air, water, and soil pollution; strengthen tobacco control 
and capacity to tackle health risks; support health research and 
development; ﬁ nance health workforces; achieve universal 
health coverage with ﬁ nancial risk protection.
SDG=Sustainable Development Goals. NTDs=neglected tropical diseases. 
NCDs=non-communicable diseases. 
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premature deaths), which could be universal. For the 
second part (improve health care), the targets would 
have to be appropriately country-speciﬁ c. 
40% fewer premature deaths would be important even 
in high-income, low-mortality countries, but the absolute 
gain from it would be greater in countries with higher 
death rates.
Substantial reductions in premature death can be 
achieved everywhere (and, importantly, could be monitored 
in many populations).16–18 Placing the main emphasis on 
premature death and improved health care does not 
ignore disability, since many causes of disability are 
treatable, or are also important causes of death (and the 
main contributor to international variation in composite 
indices of death and disability, especially in lower-income 
countries, is premature death19). 
Changes that reduce mortality in middle age also 
beneﬁ t older people (>70 years), since the main causes of 
death and disability at 50–69 years are similar to those at 
somewhat older ages. Moreover, strategies for reducing 
adult and, particularly, child mortality should also 
include wider availability of aﬀ ordable, cost-eﬀ ective 
health care, including mental health and sexual, 
reproductive, and perinatal health services.
From targeting premature death as a whole, appropriate 
national and regional risk-reduction priorities follow. 
These priorities vary from one country to another, 
depending on current mortality rates from various 
diseases and from injuries and the costs of eﬀ ective 
action to reduce those rates, leading to population-speciﬁ c 
prioritisation of appropriate diseases and age groups.20,21
Moreover, targeting premature death could establish a 
political precedent whose eﬀ ects continue after 2030. 
This political precedent matters, since even if premature 
death decreases 40% by around 2030, 60% would remain 
to be dealt with later. Substantial further gains follow if 
appropriate priorities are adopted over the next decade or 
two. Eﬀ ective programmes to reduce particular causes of 
death or expand access to health care take many years to 
establish but, once established, can be continued.
Although many premature deaths result from other 
causes, most are caused by NCDs. Some interventions 
can aﬀ ect NCD mortality quite quickly (eg, treatment 
availability), but others take decades. For example, 
although adult smoking cessation produces fairly rapid 
beneﬁ ts, reducing uptake rates produces major beneﬁ ts 
only after many decades,22 as does childhood vaccination 
against hepatitis B and papillomavirus to avoid liver and 
cervix cancer. For governments to value such measures 
appropriately, long-term targeting of premature death 
should be institutionalised within them, reducing 2030 
mortality and laying foundations for substantial further 
reductions after 2030, when today’s children and young 
adults will be passing through middle age.
If targets are to be pursued seriously, progress towards 
them needs to be monitored. For premature death this 
monitoring requires trends only in under-70 mortality 
(which are easier to monitor reliably than trends at older 
ages). Monitoring targets that involve expected life-years 
lost (or disability-adjusted life-years lost23,24) from 
particular causes, or overall life expectancy (or healthy 
life expectancy) require trends in mortality rates at older 
ages (and disability rates), so in many countries progress 
would be diﬃ  cult or impossible to monitor reliably. 
Moreover, where life expectancy is already over 75 years, 
increasing it might be perceived as less interesting than 
reducing premature death. For robustness of measure 
and simplicity of communication, therefore, we shall, as 
the International Epidemiological Association recom-
mended,25 chieﬂ y emphasise all-cause mortality rates, 
although at all ages health care and good health, 
including mental health,26 also matter.
Except where HIV or war or other major political 
disturbances predominate, health and longevity are 
better now than they were 20, 40, or more years ago, and 
still improving. But, there are still many deaths before 
old age. Our analyses assess the substantial reductions in 
all-cause mortality from 1970 to 2010, the more recent 
changes in cause-speciﬁ c mortality from 2000 to 2010, 
and the main remaining causes of death. In view of these 
mortality trends and levels, we consider what further 
reductions in premature death could be feasible by 2030, 
if its reduction was prioritised. We conclude that an 
ambitious but possibly realistic overarching target for 
2030 is to avoid 40% of the premature deaths in every 
country where mortality in 2030 is not dominated by new 
epidemics, disturbances, or disasters.
Turning from national to global targets, a cost-eﬀ ective 
way to reduce premature death in many countries is to 
continue reducing child and maternal mortality, tuber-
culosis, HIV, and malaria, partly because programmes 
for these reductions that took years to establish are 
already in place, and death rates are decreasing.4–8,27 For 
these particular causes we propose subtargets of a 
reduction by two-thirds in global deaths in 2030, 
compared with numbers expected at 2010 death rates. 
This would require moderate further acceleration of 
current progress, which would require better health care 
and substantial political eﬀ ort.
We also propose, based on the World Health Assembly 
resolution on under-70 mortality from NCDs,28 subtargets 
of a reduction by a third in the global number of 
premature deaths not only from NCDs but also from the 
remaining causes at ages 5–69 years (other communicable 
diseases and injuries). These reductions by a third would 
again require substantial programmes, diﬀ erent for 
diﬀ erent diseases (and for fatal accidents), to accelerate 
current rates of progress moderately. 
If achieved, these subtargets would halve under-50 
mortality, reduce global deaths at 50–69 years by about a 
third (mostly by reducing NCDs), and hence reduce 
under-70 mortality by about 40%. Before further 
discussion, we review recent and current global and 
national mortality levels and trends.
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Methods
Many populations lack vital registration (and things were 
worse in past decades), so mortality trend estimates for 
them are approximate. We used UN-based mortality 
estimates (which should suﬃ  ce for our main purposes) to 
assess trends, but we also cite other sources. To estimate 
overall mortality rates and trends for the whole world; for 
the four World Bank income-based country groupings; for 
the 25 most populous countries (which include 75% of 
global 2010 population); and for the 164 countries with 
projected 2030 population greater than 1 million (appendix 
pp 10–13), we chieﬂ y used UN Population Division (UNPD) 
historical life tables.29 These cover each ﬁ ve-year time 
period from 1950 to 2010, with medium-fertility projections 
for 2010–15. For every ﬁ fth year from 1970 to 2010, we 
estimated the death rates in it by averaging the age-speciﬁ c 
risks in the 5-year periods before and after it (so our 1970 
rates describe risks in 1965–75); this method smooths out 
any sudden mortality changes. For global under-5 mortality, 
we also cite the (broadly similar) estimates from the UN 
Inter-Agency working group.6 Results for both sexes are 
combined, but the appendix gives sex-speciﬁ c data.
From the historical life tables, we extracted for parti cular 
calendar years (1970–2010) the risks in the age ranges 0–4, 
5–49, or 50–69 years, deﬁ ning risk as the probability that 
someone who survived to the start of an age range dies in 
it. Although our main interest is in under-70 mortality, to 
describe approximate patterns of mortality up to age 
100 years we took the death rates at 85–89, 90–94, and 
95–99 years as the rate in the previous age group multiplied 
by the ratio of the rate at 80–84 to that at 75–79 years.
Cause-speciﬁ c mortality rates for 2000 and 2010 for the 
world as a whole and for each of the four World Bank 
income groupings (appendix pp 14–17) were from the 
WHO Global Health Observatory.30 Application of these 
2000 and 2010 rates to the UNPD medium-fertility 
projection of the 2030 population yielded two numbers 
of deaths, comparison of which gave the change (% per 
decade); this is also the change in the death rate from 
2000 to 2010, if standardised to the projected 2030 
population being analysed. Such age-standardised 
comparisons avoid issues of competing risks.
Role of the funding source:
The funders had no role in study design, data collection, 
analysis interpretation, or writing of the report. OFN, PJ, 
and RP had full access to all data. OFN and RP had ﬁ nal 
responsibility for submitting for publication.
Results
Between 1970 and 2010, mortality decreased substantially, 
particularly in young children (ﬁ gure 1A). From 1970 to 
2010, under-5 mortality fell by almost two-thirds (from 
14% to 5%, absolute diﬀ erence 9%), under-50 mortality 
almost halved (from 28% to 15%, absolute diﬀ erence 
13%), and under-70 mortality fell by a third (54% to 36%, 
absolute diﬀ erence 18%).
The World Bank groups countries as low, lower-middle, 
upper-middle, and high income.31 Figure 1B describes 
2010 mortality in these four groups, showing the excess 
premature mortality in lower-income countries (although 
even they now have lower mortality than the world as a 
whole in 1970).
With regard to mortality changes by age group between 
1970 and 2010, the trends at 0–4 and 50–69 years were 
uniformly favourable, but the generally favourable trend 
at 5–49 years was slowed in the 1990s (and, in low-income 
countries, temporarily reversed) by HIV (ﬁ gure 2).
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Figure 1: Risk of death versus age for the world in 1970 and 2010 (A) and for country income groupings in 
2010 (B)
(A) Risk of death versus age for world in 1970 and in 2010. (B) Risk of death versus age for low-income, lower-
middle-income, upper-middle-income, and high-income countries in 2010. Results for both sexes are combined; 
appendix p 3 gives sex-speciﬁ c results. 1970 risk is the mean of 1965–70 and 1970–75 risks, and the risk of 2010 is 
the mean of 2005–10 and projected 2010–15 risks. For historical comparison, the 1910 and 2010 risks for England 
and Wales are given. 
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The absolute 1970–2010 reductions in risk of death at 
ages 0–4 and 5–49 years were much steeper in low-income 
than in high-income countries. Still, however, substantial 
risk remains in low-income countries (low-income vs 
high-income risks: 10% vs <1% at 0–4 years and 18% vs 
6% at 5–49 years). The risk of a person aged 50 years 
dying at ages 50–69 years decreased by a third (from 36% 
in 1970 to 24% in 2010), with similar absolute risk 
reductions in low-income and high-income countries.
Within each income group, diﬀ erent countries had 
diﬀ erent mortality patterns. Figures 3 and 4 show the 
1970–2010 trends in risk at 0–4, 5–49, 50–69, 0–49, and 
0–69 years in the 25 most populous countries, which 
include 75% of 2010 world population. The appendix 
(pp 6–9) gives separate results for male and female 
mortality rates, which diﬀ ered little at 0–4 years but 
showed some sharp contrasts at older ages. Risks and 
trends are somewhat untrustworthy for countries 
without vital statistics, but nevertheless diﬀ erences 
between countries are remarkable, as is the general 
decrease in mortality within each age range, except in the 
few countries where special factors (HIV, war, or vodka) 
supervened.
Figure 3A shows trends at 0–4 years. By 2010, there 
was a more than 50-fold variation in risk, from 18% in 
DR Congo to 0·3% in Japan and western Europe. War 
and political disruption aﬀ ected 1970 (ie, 1965–75) risks 
in Bangladesh, China, DR Congo, Ethiopia, Nigeria, 
South Africa, and Vietnam. Over the past 20 years, 
however (apart from South Africa, where HIV super-
vened, and DR Congo, where political disruption 
supervened), the proportional decreases in under-5 
mortality were substantial everywhere, with striking 
absolute reductions (≥15%) in Bangladesh, Egypt, 
Ethiopia, Iran, and Turkey. Since most under-5 deaths 
were in south Asia and sub-Saharan Africa, worldwide 
trends depend mainly on these regions.
Figure 3B shows trends at 5–49 years. By 2010, we noted 
a 10-fold variation, from nearly 40% in South Africa 
(where HIV predominates) to 4% in Japan and western 
Europe. There was a general decrease, except in South 
Africa and Russia. HIV caused the extreme South African 
ﬂ uctuation, and the ﬂ uctuation in Thailand.27 The extreme 
Iranian ﬂ uctuation reﬂ ects 1980s war deaths, and the 
Russian pattern reﬂ ects mortality from spirits (decreasing 
since 2005 [appendix p 19], but still substantial).32
Figure 4A shows trends in the risk of a 50-year-old 
dying at 50–69 years. By 2010, we noted four-fold 
variation, with the highest rates in sub-Saharan Africa 
and Russia. Elsewhere, risk decreased. The decreases 
were slight in three countries (Philippines, Egypt, and 
Pakistan) and largest in Iran. In several high-income 
countries the risk halved during 1970–2010, helped since 
1990 by reductions in tobacco deaths in the USA and 
Europe (appendix p 20–21).
Finally, ﬁ gure 4B combines the foregoing trends at ages 
0–4, 5–49, and 50–69 years to contrast the trends in 
under-50 mortality and in under-70 mortality. In 2010, 
under-70 mortality varied from two-thirds in sub-Saharan 
Africa (similar to England in 1910; ﬁ gure 1) to only 14% in 
Japan and Italy. Where risks are high, however, under-70 
mortality can obscure trends; eg, in South Africa and Iran 
the ﬂ uctuations due to HIV or war are notably less 
extreme at 0–69 years than at 0–49 years.
Trends during the past 10 years (2000–10) reﬂ ect more 
recent circumstances (and are unaﬀ ected by the large 
increase in HIV mortality before 2000, which ceased). 
Table 1 gives numbers of deaths at 0–4, 5–49, and 
50–69 years expected in each country, or group of 
countries, in 2030 if its 2010 mortality rates still applied 
to its 2030 population. Death rates are falling, however, 
so numbers actually seen in 2030 will be lower. Hence, it 
also gives the change in mortality rates (% per decade) 
from 2000 to 2010. If such changes continue for another 
20 years, deaths in 2030 would be reduced by almost 
twice the change per decade (ﬁ nal column of table 1; 
decreases per decade of 18% or 42% yield 20-year 
reductions of a third or two-thirds). Results are given 
separately for the world, four World Bank income groups, 
the EU, the 25 most populous countries (sorted by 2030 
death numbers), and 164 countries with a population of 
more than 1 million (appendix pp 10–13).
Worldwide in 2030, 41 million premature deaths 
would be expected at 2010 death rates (7, 12, and 
22 million at 0–4, 5–49, and 50–69 years). These 
numbers would be slightly increased by stratiﬁ cation 
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Figure 2: 40-year trends, 1970–2010, in risks of dying in selected age ranges for the world (left), and (right)
four World Bank groupings of countries (low-income to high-income)
Risks are for those who have already survived to the start of the relevant age range. Results for both sexes are 
combined; appendix p 5 gives sex-speciﬁ c results. Risks average previous and subsequent 5-year time periods (so 
1970 risk is the mean of 1965–70 and 1970–75 risks; 2010 risk is the mean of 2005–10 risks and UNPD projection for 
the 2010–15 risks), smoothing any sudden changes. Details of these graphs are tabulated in the appendix (pp 25–26). 
2 billion deaths at ages 0–69 years were recorded from 1965 to 2010.
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Figure 3: 40–year trend lines, 
1970–2010, for 25 most 
populous countries in risks of 
dying in selected age ranges
(A) Risk of death at ages 
0–4 years. (B) Risk, at age 
5 years, of death at ages 
5–49 years. Results for both 
sexes are combined; appendix 
pp 6–7 give sex-speciﬁ c results. 
Risks average the previous and 
subsequent 5-year time 
periods (so the 1970 risk is the 
mean of the 1965–70 and 
1970–75 risks), smoothing any 
sudden changes.
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Figure 4: 40–year trend lines, 
1970–2010, for 25 most 
populous countries in risks of 
dying in selected age ranges
(A) Risk, at age 50 years, of 
death at ages 50–69 years. 
(B) Risks, ages 0–49 years and 
0–69 years. Results for both 
sexes are combined; appendix 
pp 8–9 give sex-speciﬁ c 
results. Risks average the 
previous and subsequent 
5-year time periods (so the 
1970 risk is the mean of the 
1965–70 and 1970–75 risks), 
smoothing any sudden 
changes.
Articles
246 www.thelancet.com   Vol 385   January 17, 2015
by country income group (table 1). In 2000–10, under-5 
mortality decreased by about a third per decade and 
mortality at 5–49 and 50–69 years decreased by about a 
sixth per decade. If similar decreases per decade 
continue (which they might not, without substantial 
eﬀ ort), this would reduce 2030 under-70 deaths by 
about a third, to 27 million (3 million at 0–4 years, 
8 million at 5–49 years, and 16 million at 50–69 years).
In low-income countries the proportion of premature 
deaths that are in childhood is still substantial, so a 
substantial absolute reduction in premature death is still 
possible. India, China, Nigeria, and Indonesia account for 
20 million of the 41 million premature deaths in table 1; 
all are currently on track for a 2010–30 reduction of about 
a third (ie, 18% per decade). Next in absolute numbers of 
premature deaths are DR Congo and Pakistan, with 
Age 0–4 Age 5–49 Age 50–69 Age 0–69
Deaths 
in 2030, 
millions
Change, 
% per 
decade*
Deaths 
in 2030, 
millions
Change, 
% per 
decade*
Deaths 
in 2030, 
millions
Change,
% per 
decade*
Deaths 
in 2030, 
millions
Change, 
% per 
decade*
(Implied % 
change per 
20 years†)
Most populous 25 countries‡
2 India 1·49 –30% 2·72 –15% 5·05 –12% 9·26 –17 (–31%)
3 China 0·28 –36% 0·92 –30% 4·71 –15% 5·91 –19 (–34%)
1 Nigeria 1·36 –31% 1·30 –12% 0·63 –7% 3·29 –20 (–37%)
2 Indonesia 0·14 –37% 0·34 –25% 0·95 –10% 1·42 –17 (–32%)
1 DR Congo 0·72 –13% 0·50 –11% 0·21 –7% 1·42 –12 (–22%)
2 Pakistan 0·34 –22% 0·34 –14% 0·52 –2% 1·20 –12 (–22%)
3 Russia 0·02 –46% 0·33 –7% 0·77 –11% 1·12 –11 (–21%)
3 Brazil 0·07 –30% 0·32 –17% 0·66 –15% 1·05 –16 (–30%)
4 USA 0·04 –12% 0·25 –9% 0·76 –18% 1·04 –15 (–28%)
1 Ethiopia 0·30 –43% 0·43 –38% 0·22 –25% 0·95 –37 (–61%)
1 Bangladesh 0·14 –44% 0·22 –27% 0·51 –4% 0·86 –19 (–35%)
3 South Africa 0·06 –21% 0·39 22% 0·24 –1% 0·70 +8 ··
2 Philippines 0·08 –24% 0·20 –10% 0·35 –4% 0·63 –9 (–17%)
3 Mexico 0·04 –36% 0·12 –17% 0·27 –15% 0·43 –18 (–33%)
2 Egypt 0·05 –38% 0·11 –17% 0·28 –4% 0·43 –13 (–24%)
2 Vietnam 0·02 –30% 0·11 –11% 0·28 –1% 0·41 –6 (–11%)
1 Myanmar 0·05 –20% 0·12 –15% 0·24 –7% 0·41 –12 (–22%)
3 Thailand 0·01 –33% 0·09 –24% 0·25 –8% 0·34 –14 (–26%)
3 Iran 0·03 –39% 0·10 –20% 0·20 –20% 0·33 –22 (–39%)
3 Turkey 0·02 –53% 0·09 –26% 0·17 –19% 0·29 –26 (–45%)
4 Japan <0·01 –29% 0·04 –15% 0·19 –18% 0·24 –18 (–32%)
4 Germany <0·01 –23% 0·03 –27% 0·20 –20% 0·23 –21 (–38%)
4 UK <0·01 –20% 0·03 –14% 0·13 –23% 0·17 –22 (–38%)
4 France <0·01 –26% 0·03 –25% 0·12 –17% 0·16 –19 (–34%)
4 Italy <0·01 –38% 0·02 –30% 0·12 –23% 0·14 –24 (–43%)
Total, 25 most populous countries 5·3 –30% 9·2 –17% 18·0 –13% 32·4 –17 (–32%)
European Union§ 0·03 –30% 0·25 –22% 1·2 –19% 1·5 –20 (–36%)
World Bank grouping
1 Low-income 3·0 –34% 3·9 –22% 2·7 –12% 9·6 –24 (–43%)
2 Lower-middle 3·9 –31% 6·3 –11% 9·4 –10% 19·6 –16 (–29%)
3 Upper-middle 0·6 –43% 2·8 –20% 8·2 –20% 11·6 –22 (–38%)
4 High-income 0·1 –26% 0·6 –16% 2·4 –15% 3·1 –15 (–28%)
Total, four World Bank groupings 7·6 ·· 13·6 ·· 22·7 ·· 43·9 ·· ··
World, at global mortality rates ¶ 7·2 –34% 12·4 –17% 21·7 –15% 41·3 –19 (–35%)
*The death rates of exact year 2000 and the (lower) death rates of exact 2010 were applied to the 2030 population (UNPD medium-variant projection), yielding 2 numbers of 
2030 deaths; change (% per decade) compares them. This change is identical to the change in the age-standardised death rate from 2000 to 2010, if both rates are 
standardised to the age distribution of the relevant 2030 population. †Change (%) over 20 years (2010–30) if the rate of change (% per decade) during 2000–10 were to 
continue. ‡Country name, and World Bank income grouping: 1=low, 2=lower-middle, 3=upper-middle, 4=high income. §All 28 states that were EU members in 2010, 
regardless of their status in the year 2000. ¶No allowance for population changes in income distribution, so numbers lower than totals for the 4 World Bank groups.
Table 1: 25 most populous countries, and various groupings of countries: numbers of premature deaths in 2030 by age (years), if 2010 rates applied to 
2030 populations, and current rate of change (% per decade, 2000–10) in age-standardised death rates
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political disruption and shallower rates of decline, Russia, 
where much premature mortality is from vodka 
consumption and tobacco use (hence avoidable), and the 
USA and Brazil, where current trends suggest 20-year 
decreases nearer 30% than 40%. The greatest decrease 
was in Ethiopia, and the only increase was in South 
Africa. In sub-Saharan Africa, large reductions in 
premature death would be possible with political stability 
and HIV control.
Some causes of death are much more susceptible to 
control than others. Table 2 breaks down the global 
numbers by cause and age; the appendix (pp 14–18) 
shows these data for each income group. The age 
distributions of diﬀ erent causes help explain why rates 
of decrease are steeper at 0–49 years than at 50–69 years. 
In the subtotals (table 2; table 3), projected deaths in 
2030 from communicable, neonatal, maternal, and 
nutritional causes number 10 million at 0–49 years and 
2 million at 50–69 years. By contrast, those from 
non-communicable diseases number 6 million at 
0–49 years and 18 million at 50–69 years. As rates of 
decrease are twice as great for communicable disease 
as for other causes, under-50 mortality is falling 
particularly rapidly.
Age 0–49 Age 50–69 Age 0–69 (Age ≥70)
Deaths 
in 2030, 
millions
Change, 
% per 
decade*
Deaths 
in 2030, 
millions
Change, 
% per 
decade*
Deaths 
in 2030, 
millions
Change, 
% per 
decade*
Deaths 
in 2030, 
millions
Communicable, perinatal, 
maternal, or nutritional
Neonatal† 2·6 –23% ·· ·· 2·6 –23% ··
Respiratory infection 1·5 –35% 0·7 –17% 2·2 –31% (2·2)
HIV/AIDS 1·7 –14% 0·3 –19% 2·0 –15% (0·0)
Diarrhoea 1·1 –40% 0·4 –25% 1·5 –37% (0·6)
Tuberculosis 0·5 –39% 0·6 –41% 1·0 –40% (0·5)
Malaria 0·6 –30% <0·1 –19% 0·7 –30% (0·0)
Nutritional deﬁ ciencies 0·4 –24% 0·1 –28% 0·5 –24% (0·3)
Meningitis 0·4 –29% 0·1 –13% 0·4 –27% (0·1)
Childhood cluster‡ 0·3 –67% ·· ·· 0·3 –67% ··
Maternal 0·3 –37% ·· ·· 0·3 –37% ··
Other communicable 0·8 –22% 0·4 –8% 1·1 –18% (0·5)
Non-communicable diseases
Vascular or diabetic 1·8 –17% 8·4 –16% 10·1 –17% (21·1)
Neoplastic 1·4 –14% 5·0 –9% 6·4 –10% (6·8)
Chronic respiratory 0·3 –30% 1·7 –28% 2·0 –28% (4·8)
Cirrhotic 0·3 –14% 0·8 –11% 1·1 –12% (0·4)
Other digestive 0·3 –21% 0·6 –19% 0·9 –20% (1·1)
Renal 0·3 –14% 0·5 –2% 0·8  –7% (1·0)
Congenital 0·6 –11% ·· ·· 0·6 –11% (0·0)
Other non-communicable 0·7 +3% 0·7 +12% 1·4  +7% (2·0)
Injuries
Non-road-traﬃ  c accidents 1·7 –17% 0·8 –8% 2·4 –14% (1·2)
Road traﬃ  c accidents 1·0 +2% 0·4 +15% 1·4  +5% (0·3)
Suicide 0·6 –23% 0·3 –25% 0·9 –24% (0·2)
Homicide or war 0·5 –20% 0·1 –29% 0·6 –22% (0·0)
Subtotals: cause categories
Communicable, perinatal, 
maternal or nutritional
10·2 –31% 2·6 –25% 12·8 –30% (4·1)
Non-communicable diseases 5·8 –15% 17·5 –14% 23·3 –14% (37·2)
Injuries 3·6 –14% 1·6 –9% 5·2 –13% (1·7)
World total: All causes 19·6 –24% 21·7 –15% 41·3 –19% (43·0)
*The death rates of exact 2000 and the (lower) death rates of exact 2010 were applied to the 2030 population (UNPD medium-variant projection), yielding two numbers of 
2030 deaths; change (% per decade) compares them. NB: This change is identical to the change the age-standardised death rate from 2000 to 2010, if both rates are 
standardised to the age distribution of the world population in 2030. †Conditions arising in the perinatal period (ICD-10 P00-P96); mostly avoidable. NB: Excludes congenital 
malformations. ‡Diphtheria, pertussis, tetanus, poliomyelitis, measles; all are vaccine-preventable.
Table 2: Worldwide numbers of premature deaths by cause and age (years) in 2030, if 2010 rates applied to 2030 world population, and current rate of 
change (% per decade, 2000–10*) in age-standardised death rates
Articles
248 www.thelancet.com   Vol 385   January 17, 2015
Subdividing further, there was no material increase 
from 2000 to 2010 in any major cause except traﬃ  c 
accidents. Mortality from communicable diseases 
decreased rapidly (except that HIV rose for a few years, 
then fell). Mortality from non-communicable diseases 
decreased moderately (except that chronic respiratory 
disease decreased rapidly). Mortality decreased more 
slowly from injuries than from disease; although suicide 
and homicide (which includes war deaths) decreased, 
increased traﬃ  c deaths were only just outweighed by 
decreases in other fatal accidents.
For some populations, striking trends in all-cause, 
cancer or vascular mortality (appendix pp 19–24) illustrate 
vividly the importance of particular factors—HIV, 
tobacco, alcohol, vascular medication, or under-5 
mortality. Where death rates remain high, substantial 
absolute risk reductions are possible.
Discussion
In old age death is inevitable, but death before old age 
is not.33 World life expectancy is now just over 70 years, 
and most deaths before that age are avoidable. In some 
countries with reliable data, under-50 mortality is lower 
than 5%, under-70 mortality is lower than 20%, and 
both are still falling. In many countries, however, 
substantial risks remain, and there are substantial 
unmet health-care needs. Mortality and morbidity can 
be combined into composite indices such as healthy life 
expectancy (HALE) or disability-adjusted life-years 
(DALYs), but such indices are diﬃ  cult to monitor in 
low-resource environments, and correlate closely with 
premature death.19,34
Even mortality rates and trends are not known exactly 
(as many high-mortality countries lack reliable vital 
statistics), and our estimates of them, based only on UN 
and WHO statistics, could be made somewhat more 
reliable by seeking further evidence.4–8,35,36 The present 
evidence is, however, reliable enough to help formulate 
reasonable mortality reduction targets. Generally, 
mortality rates have been falling for decades, particularly 
in childhood, despite sharp ﬂ uctuations in some 
populations due to HIV or direct or indirect eﬀ ects of 
political disruption. Both the 40-year trends in ﬁ gures 1–4 
and the 10-year trends in tables 1–2 are of interest. We 
noted a larger decrease during 2000–10 than in the 1990s, 
due partly in the past few years to eﬀ orts to achieve the 
MDGs,4–8,27,37 and our proposed targets (panel 2) build on 
the progress already being achieved.
Still, however, malaria, HIV, tuberculosis, and 
maternal and child mortality would, at 2010 death rates, 
cause about 9 million deaths in 2030 (7 million at 
0–4 years plus 2 million at 5–49 years, out of a total of 
about 20 million under-50 deaths; table 3). If existing 
eﬀ orts to control them and expand health care are 
intensiﬁ ed in epidemiologically eﬃ  cient ways (which 
may involve some strategies that reﬂ ect transmission 
patterns, and not just passive service provision), then 
from 2010 to 2030 it could be possible to reduce 
mortality from them by two-thirds; they fell by about a 
third per decade from 2000 to 2010.
This will, however, be a challenging target even in areas 
free from conﬂ ict. Reducing malaria mortality by a third 
during the past decade required substantial, complex 
eﬀ orts, and global commitment, and continuing to 
reduce it by about a third per decade could be increasingly 
diﬃ  cult. Likewise, to continue successful control of HIV 
and tuberculosis, major political commitment will be 
needed, even if improved diagnostics and treatments can 
be widely deployed.13
For maternal mortality, the decrease noted in table 2 is 
37% per decade, but this estimated decrease is steeper 
than other studies suggest.6,7 If the current annual 
decrease is about 30% per decade, and this decrease can 
be maintained for 20 years, maternal mortality would be 
halved. Hence, the rate of decrease would have to steepen 
substantially by 2020 to achieve a two-thirds reduction by 
2030. This ambitious target would mean a reduction to 
77 per 100 000 livebirths, comparable with the targets of 
70 and 94 suggested by others (panel 1).1,13
Finally, under-5 mortality accounts for the largest 
number of MDG-targeted deaths. Both MDG4 and our 
suggested target relate to under-5 mortality as a whole, 
since this is more reliably measurable than particular 
components of under-5 mortality. But, these particular 
components are of separate interest. The steepest 
decrease is the 67% fall within just one decade 
in mortality from the childhood cluster of vaccine-
preventable diseases, illustrating the importance of 
national and international vaccination programmes. 
Although mortality rates from many other infective 
causes are also decreasing steeply (eg, 30–40% per 
decade), neonatal causes of death are not.5,13,38–40 These 
Age 0–4 Age 5–49 Age 50–69
Neonatal or maternal ··/2·5 0·2/0·3 ··
HIV ··/0·1 1·0/1·5 0·2/ 0·3
TB and malaria ··/0·5 0·3/0·5 0·4/ 0·7
Other communicable* ··/2·8 0·6/1·9 0·5/ 1·6
Non-communicable† ··/0·9 1·6/4·9 5·8/17·5
Fatal injuries‡ ··/0·4 1·1/3·3 0·5/1·6
All deaths, by age§ 4·8/7·2 4·9/12·4 7·5/21·7
Cumulative deaths, 
starting from birth
·· Ages 0–49: 
9·7/19·6
Ages 0–69: 
17·3 /41·3
Data are targeted reduction/number at 2010 rates. *Includes malnutrition, but, 
mostly pneumonia and diarrhoea (before and after age 5 years). †At ages 0–4 years, 
most NCD deaths are from congenital disease. ‡Most fatal injuries are accidents, 
rather than suicide or homicide. §All deaths, by summation over four income-based 
groups of countries: ages 0–4 years, 5·0 million/7·6 million; ages 5–49 years, 
5·4 million/13·6 million; ages 50–69 years, 8·1 million/22·7 million. Target of 
two-thirds reduction in under-5 mortality as a whole is not subdivided by cause.
Table 3: Premature deaths (million) in 2030 population at unaltered 
2010 death rates, and targeted reductions that would be avoided by 
reductions of two-thirds in child, maternal, tuberculosis, HIV, and 
malaria deaths, and of a third in other deaths
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causes arising in the neonatal period are largely 
preventable or curable (and do not include congenital 
causes). But, serious adoption of the target of a two-thirds 
reduction in under-5 mortality from 2010 to 2030, if 
backed by appropriate resources, would accelerate 
progress. Achievement of this target would reduce 
under-5 mortality to just below 20 per 1000 livebirths, 
comparable with targets suggested by others (panel 1).9–13
For mortality at 5–69 years from the remaining com-
municable diseases (chieﬂ y diarrhoea and pneumonia), 
the rate of decrease during 2000–10 was not as steep, so 
a smaller rate of reduction should perhaps be targeted. 
A reduction of a third over 20 years would represent 
moderate acceleration of the decrease during the previous 
decade. This reduction would require substantially 
improved health-care delivery to the subpopulations who 
are still at relatively high risk of death from curable 
infections.
If communicable disease mortality falls substantially, 
NCDs and injuries will increasingly predominate. 
Hence, without substantial extra eﬀ orts to reduce them, 
all-cause mortality is unlikely to decrease as rapidly in 
future decades as in the past decade. The reduction 
actually achieved in NCD mortality will be a key 
determinant of the reduction in overall mortality 
(particularly at 50–69 years, where NCDs cause more 
than 80% of all premature deaths), and UN/WHO 
initiatives are already addressing NCD control.28,41,42
The 2012 WHO 25 × 25 resolution targeted a 25% 
reduction from 2010–25 in NCD mortality at ages 
30–69 years, specifying as 2025 subtargets changes in 
various NCD determinants.28 The most important was 
30% reduction in smoking, which in 2010 caused about 
a quarter of all cancer deaths in Europe and America 
(plus even more deaths from other diseases), and is 
already a major cause of death in China, India, and 
elsewhere in Asia. Fortunately, quitting works; smokers 
who stop before age 40 years (preferably well before 40) 
avoid more than 90% of the risk.22 Hence, the 25 × 25 
resolution supported the Framework Convention on 
Tobacco Control, whose many recommendations 
include major increases in speciﬁ c excise taxes. 
Governments make about US$300 billion per year 
directly or indirectly from tobacco. If increases in excise 
tax were to double real current cigarette prices, 
particularly aﬀ ecting cheaper brands, this would reduce 
smoking by about a third, yet increase what governments 
make from tobacco to about US$400 billion per year, in 
today’s dollars.43 The 25 × 25 resolution also targeted 
dangerous patterns of alcohol consumption (the 
predominant cause of premature death in Russia; 
appendix p 19); halting the present rise in obesity; and 
secondary prevention (eﬀ ective, aﬀ ordable treatment of 
those already identiﬁ ed as having disease, mainly with 
safe generics that do not require tertiary care).34 The 
global decrease of 15% per decade in NCD mortality 
during 2000–10 should be somewhat exceeded during 
the 2020s if there is good compliance with the 25 × 25 
resolution over determinants of NCD mortality, with 
even greater eﬀ ects thereafter.
Table 3 shows the importance, particularly at 5–49 years, 
of fatal injuries (mainly accidents, but also suicide and 
homicide). Alcohol is a major cause of accidents and other 
fatal injuries, and the main cause of premature death in 
some populations. With political commitment, practicable 
restrictions on alcohol pricing, advertising and convenience 
of purchase could in some populations substantially reduce 
these risks. Successful programmes to reduce mortality 
from suicide (within wider mental health programmes), 
homicide and, particularly, road accidents and the (more 
frequent) other accidents will be as complex to plan and 
carry through as those for disease control, and should 
include establishment of sustainable systems to register 
details of fatal injuries. More generally, if mortality targets 
and subtargets are adopted, appropriate epidemiological 
systems will be needed to monitor overall and cause-
speciﬁ c mortality in representative populations.16–18
Panel 2: Research in context
Previous studies
Millennium Development Goals targeted reductions from 1990 to 2015 in maternal, 
child, HIV, tuberculosis, and malaria mortality, and WHO has targeted 2010–25 reductions 
in premature (under 70 years of age) NCD mortality. To help quantify the 2010–30 UN 
Sustainable Development Goal for health (SDG3), we re-analysed data from the UN and 
WHO for recent global mortality trends to 2010.
What this study adds
Maternal, child, HIV, tuberculosis, and malaria mortality are falling so fast that reduction 
by two-thirds during 20 years (2010–30) could feasibly be targeted. Other under-70 
mortality is falling half as fast, suggesting a reduction by a third could feasibly be 
targeted. Achievement of both targets would reduce premature deaths by about 40%. 
Country-speciﬁ c results suggest 40% reduction is feasible in many populations, but would 
be challenging to achieve by 2030.
A quantitative target to accompany SDG3: 
Avoid 40% of premature deaths, and improve health care at all ages
• Overarching target for mortality: avoid 40% of the premature deaths in each country 
(the deaths before age 70 years that would occur in that country’s 2030 population at 
its 2010 death rates).
• Overarching target for health care at all ages: extend access to cost-eﬀ ective, 
aﬀ ordable treatment, including mental health and sexual, reproductive and perinatal 
services (with targets that are appropriately country-speciﬁ c)
• Subtargets for global mortality from speciﬁ c causes:
 Avoid two-thirds of child and maternal deaths;
 Avoid two-thirds of HIV, tuberculosis, and malaria deaths;
 Avoid a third of premature deaths from other communicable diseases or injuries;
 Avoid a third of the premature deaths from NCDs.
Achievement of these subtargets would halve under-50 mortality (avoiding 10 million of 
the 20 million deaths before age 50 years that would occur in the 2030 population at 
2010 death rates), as well as reducing global premature deaths by about 40% 
(avoiding 17 million of the 41 million deaths before age 70 years that would occur in the 
2030 population at 2010 death rates).
NCDs=non-communicable diseases.
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Since national and international programmes to 
reduce mortality from the problems targeted by the 
MDGs are already working, continuation of these 
programmes is an important, cost-eﬀ ective way to 
reduce overall mortality, as is substantial expansion of 
aﬀ ordable health care, including sexual, reproductive, 
and perinatal health services. For communicable, 
maternal, and child mortality, a grand downward 
convergence between rates in diﬀ erent countries could 
be largely achieved through health-system strengthening 
plus scale-up of proven, aﬀ ordable health interventions 
and relevant research and development.13,21
Although the targeted reductions in particular causes 
improve only moderately on current rates of progress, 
they will not be achieved without sustained eﬀ ort, 
targeted programmes, and additional ﬁ nance for health 
care. If achieved, they avoid about 10 million of the 
20 million deaths at 0–49 years (halving under-50 
Panel 4: Mexico46–54
From 1970 to 2010, Mexican mortality fell six-fold at ages 
0–4 years (from 12% to 2%), three-fold at ages 5–49 years 
(from 17% to 6%), and two-fold at ages 50–69 years (from 
33% to 17%). These substantial decreases, which are similar to 
those in several other countries, were about as steep before 
as after the 1990s health-care reforms (ﬁ gure 3).
Although other factors also had an important role, the major 
Mexican health-system strengthening initiatives and special 
programmes of the past three decades must have reduced 
mortality. In the 1990s, Mexico expanded the health-care 
infrastructure in poorer states and increased regular access of 
the poor to 12 essential interventions (Extension of Coverage 
Program), and in 2004 Congress extended social protection 
in health to the non-salaried. The supply of safe water and 
sanitation improved, and community-based interventions 
targeted malnutrition and common childhood infections (eg, 
National Program to Control Diarrheal Diseases [1984], 
Universal Immunization Program [1991] and Fair Start in Life 
[2002]). Vaccines were given during national health weeks, 
along with promotion of oral rehydration. In 1997, a 
conditional cash transfer programme began, enhancing the 
capabilities of families in extreme poverty.
Will premature mortality continue to decline steeply? As 
shown in table 1, under-5 mortality is still decreasing by a 
third per decade and premature mortality is now mainly at 
ages 50–69 years, where NCDs predominate and the World 
Health Assembly 25 × 25 resolution on NCDs applies (panel 1). 
Secondary prevention, a 30% reduction in smoking and a halt 
to the rise in adiposity are needed. In urban Mexico, 20% 
smoke, a diﬃ  cult-to-quantify proportion drink hazardously, 
and by middle-age 32% are obese, 16% are diabetic, and half 
have high blood pressure or cholesterol, mostly undiagnosed 
or under-treated. The new National Strategy for Control of 
Obesity and Diabetes [2013] includes (1) health promotion, 
NCD prevention and monitoring; (2) early risk factor 
identiﬁ cation, including diabetes; and (3) ﬁ scal policies for 
health, including new taxes (eg, US$0·07 per L on sugary 
drinks and 8% on high-calorie junk food). Likewise, Mexican 
taxes are only 62% of cigarette prices; raising this to 75% 
could reduce numbers of people smoking by a few million yet 
generate tens of billions of pesos in annual revenue. Despite 
all these major issues, however, Mexican death rates have 
never been lower, and are still falling steeply. 
Panel 3: Ethiopia4,6,39,44
Ethiopian health has progressed remarkably since 1990: the 
number of new HIV infections declined by 90% and under-5 
mortality by 67%. The reasons (apart from ending armed 
conﬂ ict and its consequences) include health-care reforms 
with, as key factors, community empowerment and 
ownership through the ﬂ agship Health Extension Program 
(HEP); sustained political commitment at all levels; 
innovative solutions to problems like task-shifting; emphasis 
on building a resilient health system by leveraging domestic 
and international support; and ensuring equity of access to 
primary health care, providing key priority services and 
ensuring the worse oﬀ  are not left behind.
In 1990, under-5 mortality 20·4%, mortality from 
tuberculosis, malaria, and HIV was high, and life expectancy 
was 45 years. Health policy decisions in 1993 articulated the 
changes needed to reverse the deteriorating health situation 
by treatment plus health promotion and disease prevention. 
10 years later, the HEP was implemented at scale in all 
regions. HEP is supported by 38 000 rural and urban 
government-salaried Health Extension Workers, trained and 
equipped to support implementation of 16 “health 
promotive, disease preventive and basic curative health 
service packages” and brings services to the door-steps of 
each household, which makes it diﬀ er from conventional 
health-care delivery, where people go with their problems to 
health facilities.
HEP is coupled with accelerated expansion of health facilities 
(health posts, health centers, and hospitals), human resources 
(nurses, midwives, laboratory and pharmacy professionals, and 
doctors) and transformational change in the pharmaceutical 
funding and supply system. Health, and health reform, has 
been greatly helped by social changes involving peace, 
avoidance of famines, economic growth, education, safe 
drinking water, and clean energy. Health indicators have 
improved profoundly since 1990: under-5 mortality fell to 
6·8% (surpassing MDG4 3 years early); tuberculosis and 
malaria mortality halved, and life expectancy rose to 65 years. 
The mortality decreases were particularly steep during the past 
decade (2000–10; table 1, ﬁ gure 3). If recent past 
achievements predict future attainments, during 2010–30 
Ethiopia will roughly halve the remaining risks of premature 
death, especially with its plans for coordinated and sustained 
mitigation of mortality and morbidity from injuries and NCDs.
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mortality), and about 17 million (40%) of the 41 million 
deaths at 0–69 years (table 3). They do not, however, 
greatly change global population growth in old age, 
which is driven more by intergenerational demographic 
changes than by the moderate proportional changes in 
the probability of reaching old age seen in ﬁ gure 1A. 
Likewise, moderate proportional increases in the 
probability of surviving childhood would have little direct 
eﬀ ect on the dynamics of population growth, and may 
well help limit reproduction rates.23
Reducing premature death is a ﬂ exible target that can be 
pursued in diﬀ erent ways in diﬀ erent countries, according 
to their mortality patterns and resources. In low-income 
countries, the number of premature deaths in 2030 at 
2010 death rates will be three times as great before age 
50 years (6 million) as at 50–69 years (2 million), whereas 
in upper-middle-income plus high-income countries the 
opposite is true (4 million before age 50 years vs 11 million 
at 50–69 years; appendix pp 14–18).
Countries with high under-50 mortality (such as 
Ethiopia, panel 3) can prioritise reducing mortality from 
communicable, perinatal, and maternal causes, and 
mortality from injuries (mainly accidents rather than 
suicide or homicide). Investing in cost-eﬀ ective health 
care to achieve this yields economic returns and 
substantially improves life expectancy.13,45 (The Disease 
Control Priorities Project keeps a wide range of 
health-related interventions under review to determine 
their feasibility and  cost-eﬀ ectiveness.21)
Countries with low under-50 mortality (such as 
Mexico, panel 4) might prioritise controlling mortality 
from NCDs, which predominate in the 50–69 year age 
group; NCD control also reduces disability. Where social 
inequalities within countries strongly aﬀ ect mortality, 
emphasis on overall mortality and aﬀ ordable access 
should promote equity by targeting those at highest 
risk.55 China’s recently introduced nationwide health 
insurance system now covers 20% of the world’s 
population and should improve equity.
Returning to the 2016–30 SDG for health, whatever 
is proposed should balance aspiration with technical 
feasibility,15 and should engender better vital statistics.16–18 
The current proposal for SDG3 (panel 1) could be 
accompanied by something that is in part quantitative, 
feasible and measurable, such as “Avoid 40% of the 
premature deaths in each country, and improve health 
care at all ages”, especially if this is accompanied by 
appropriate subtargets (panel 2).
Indeed, in some populations the subtarget of “Halve 
under-50 mortality” might be given much greater 
emphasis than the main target,56 whereas in others “Avoid 
a third of premature deaths from NCDs” might do so. In 
all cases, however, reduction in fatal injuries (as well as in 
medical causes of death) would also be important. If the 
total number of premature deaths is to be reduced, current 
national age-speciﬁ c, cause-speciﬁ c mortality patterns 
should be major deter minants of national priorities.
Even in upper-income, low-mortality countries, 
avoiding about 40% of the deaths before age 70 years 
would be important, and should be achievable. In 
countries with higher risks of death in childhood and 
early adult life, avoiding 40% of the premature deaths 
yields larger absolute gains, and should be more easily 
achievable, at least in areas free of political disruption 
and war.
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